Cart

“Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Thumbnail image	Product	Price	Quantity	Subtotal
×		Childhood Separation Anxiety Disorder and Panic Disorder: Differences Between Respiratory and Nonrespiratory Subtypes PDF	$40.00	Childhood Separation Anxiety Disorder and Panic Disorder: Differences Between Respiratory and Nonrespiratory Subtypes PDF quantity	$40.00
×		Suicide and the Elderly During the COVID-19 Pandemic: An Overview of Different Suicide Theories PDF	$40.00	Suicide and the Elderly During the COVID-19 Pandemic: An Overview of Different Suicide Theories PDF quantity	$40.00
×		Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000 PDF	$40.00	Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000 PDF quantity	$40.00
×		Sleep Disturbance in Chronic Military-Related PTSD: Clinical Impact and Response to Adjunctive Risperidone in the Veterans Affairs Cooperative Study #504 PDF	$40.00	Sleep Disturbance in Chronic Military-Related PTSD: Clinical Impact and Response to Adjunctive Risperidone in the Veterans Affairs Cooperative Study #504 PDF quantity	$40.00
×		Benzodiazepine and "Z-Drug" Dependence: Data From a Tertiary Care Center PDF	$40.00	Benzodiazepine and "Z-Drug" Dependence: Data From a Tertiary Care Center PDF quantity	$40.00
×		Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission PDF	$40.00	Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission PDF quantity	$40.00
×		Efficacy and Tolerability of Asenapine in Acute Schizophrenia: A Placebo- and Risperidone-Controlled Trial PDF	$40.00	Efficacy and Tolerability of Asenapine in Acute Schizophrenia: A Placebo- and Risperidone-Controlled Trial PDF quantity	$40.00
×		Major Depressive Disorder and Borderline Personality Disorder Revisited: Longitudinal Interactions PDF	$40.00	Major Depressive Disorder and Borderline Personality Disorder Revisited: Longitudinal Interactions PDF quantity	$40.00
×		COVID-Related Psychosis in Adolescents: A Case-Based Review PDF	$40.00	COVID-Related Psychosis in Adolescents: A Case-Based Review PDF quantity	$40.00
×		Depression, Rumination, and Suicide Attempts in Adolescents With Mood Disorders: Sex Differences in This Relationship PDF	$40.00	Depression, Rumination, and Suicide Attempts in Adolescents With Mood Disorders: Sex Differences in This Relationship PDF quantity	$40.00
×		Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications PDF	$40.00	Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications PDF quantity	$40.00
×		Acceptability of Second-Line Antidepressant Medications Using Filled Prescription Sequences in a Nationwide Cohort Study PDF	$40.00	Acceptability of Second-Line Antidepressant Medications Using Filled Prescription Sequences in a Nationwide Cohort Study PDF quantity	$40.00
×		Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone PDF	$40.00	Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Cart totals

Subtotal	$520.00
Total	$520.00

Proceed to checkout